ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,025.17
0.96%
US Tech 100
21,466.00
0.94%
Dow Jones
42,581.78
0.89%
Brent Oil
68.495
-1.94%
Bitcoin
105,233.13
-0.24%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Arch Therapeutics Inc (CE) (ARTH) Quote

Arch Therapeutics Inc (CE)

Arch Therapeutics Inc (CE) (ARTH)

USOTC
0.1608
0.00
(0.00%)
Closed June 24 4:00PM
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.1608
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.1573 52 Week Range 1.05
Market Cap
714.654k
Previous Close
0.1608
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
8,030
Shares Outstanding
4,444,364
Dividend Yield
-
PE Ratio
-0.10
Earnings Per Share (EPS)
-1.57
Revenue
76k
Net Profit
-6.98M

About Arch Therapeutics Inc (CE)

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform wit... Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's products authorized for commercial marketing are AC5 Advanced Wound System and AC5 Topical Hemostat. Arch's development stage product candidates include AC5-GTM and AC5 Surgical Hemostat, among others. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.archtherapeutics.com
Headquarters
Carson City, Nevada, USA
Founded
-
Arch Therapeutics Inc (CE) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker ARTH. The last closing price for Arch Therapeutics (CE) was $0.16. Over the last year, Arch Therapeutics (CE) shares have traded in a share price range of $ 0.1573 to $ 1.05.

Arch Therapeutics (CE) currently has 4,444,364 shares outstanding. The market capitalization of Arch Therapeutics (CE) is $714,653.73 . Arch Therapeutics (CE) has a price to earnings ratio (PE ratio) of -0.10.

Ask ADVFN Intelligence (AI)

ARTH Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
February 07 2025
ARTH (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
January 23 2025
ARTH (0.00%)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Edgar (US Regulatory)
November 13 2024
ARTH (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
November 07 2024
ARTH (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
November 04 2024
ARTH (0.00%)

Form 8-K - Current report
Edgar (US Regulatory)
September 26 2024
ARTH (0.00%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
12-0.0302-15.81151832460.1910.2123250.157380300.19452628CS
26-0.0992-38.15384615380.260.30.157344810.20522842CS
52-0.6542-80.26993865030.8151.050.157369770.33953048CS
156-9.4392-98.3259.6180.1573827355.42032225CS
260-31.8392-99.49753245.40.157320075219.99588879CS

ARTH - Frequently Asked Questions (FAQ)

What is the current Arch Therapeutics (CE) share price?
The current share price of Arch Therapeutics (CE) is $ 0.1608
How many Arch Therapeutics (CE) shares are in issue?
Arch Therapeutics (CE) has 4,444,364 shares in issue
What is the market cap of Arch Therapeutics (CE)?
The market capitalisation of Arch Therapeutics (CE) is USD 714.65k
What is the 1 year trading range for Arch Therapeutics (CE) share price?
Arch Therapeutics (CE) has traded in the range of $ 0.1573 to $ 1.05 during the past year
What is the PE ratio of Arch Therapeutics (CE)?
The price to earnings ratio of Arch Therapeutics (CE) is -0.1
What is the cash to sales ratio of Arch Therapeutics (CE)?
The cash to sales ratio of Arch Therapeutics (CE) is 9.36
What is the reporting currency for Arch Therapeutics (CE)?
Arch Therapeutics (CE) reports financial results in USD
What is the latest annual turnover for Arch Therapeutics (CE)?
The latest annual turnover of Arch Therapeutics (CE) is USD 76k
What is the latest annual profit for Arch Therapeutics (CE)?
The latest annual profit of Arch Therapeutics (CE) is USD -6.98M
What is the registered address of Arch Therapeutics (CE)?
The registered address for Arch Therapeutics (CE) is 769 BASQUE WAY, SUITE 300, CARSON CITY, NEVADA, 89706
What is the Arch Therapeutics (CE) website address?
The website address for Arch Therapeutics (CE) is www.archtherapeutics.com
Which industry sector does Arch Therapeutics (CE) operate in?
Arch Therapeutics (CE) operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0308
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0308
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0
AACAFAAC Technologies Holdings Inc (PK)
$ 4.53
(0.00%)
0
AABVFAberdeen International Inc (PK)
$ 0.0263
(0.00%)
0
AABKFAareal Bank AG (CE)
$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
$ 0.0308
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
$ 0.55
(0.00%)
0

Discussion

View Full Feed
Crawfors Crawfors 5 minutes ago
Oh my goodness, i don't know how I missed that
but that is absolutely amazing.

Thank you for sharing that!! No doubt- that will put a LOT of cash in the bank.

$LUDG
LUDG
JW62 JW62 5 minutes ago
I believe this is a guy who was involved in a lawsuit by reachout against them who the Judge ordered a restraining order against, I don't believe he should even be messaging on this platform after seeing a message from Rick. He's probably in violation and could catch some more charges especially for
YCRM
Jake731 Jake731 5 minutes ago
Good morning all......



Bring the heat ST3



TPTW……!!!!!!!
TPTW
Zardiw Zardiw 6 minutes ago
That post won't age well..........lol

Z
Zardiw Zardiw 7 minutes ago
$CHSN - #DDAmanda Ai Evaluation - Strong Bounce Potential:

You're looking at a setup with both technical and fundamental legs. If buyers believe dilution is mostly over, CHSN could bounce to $0.30–$0.45 easily — with $0.55 in play on strong momentum

Z
CHSN
Zardiw Zardiw 8 minutes ago
$CHSN - #DDAmanda Ai Evaluation - Strong Bounce Potential:

You're looking at a setup with both technical and fundamental legs. If buyers believe dilution is mostly over, CHSN could bounce to $0.30–$0.45 easily — with $0.55 in play on strong momentum

Z
CHSN
diggitydoodle diggitydoodle 9 minutes ago
"Safe shares"...🤣🤣🤣🤣🤣🤣
What a dolt schtick to stick with. Means nothing. But, it's all some of the pumpers have. So...they're running with it! 🤣🤣🤣
Maybe today we, at least hear from the great CEO. You would think t
RNVA
ErnieBilco ErnieBilco 10 minutes ago
23 June 2025

London Stock Exchange---------CBOE BXE-----------CBOE CXE--------Aquis
---------404,590-----------------------422,267----------------110,694----------55,082
RYCEY
threewheeler threewheeler 11 minutes ago
yeap its about the top function on here, cant even tell u how many hundred posters are on my list, but its great u only need to iggy them once and it doesnt matter what board they post on, still iggied, makes IHub actually read able
AHRO
x993231 x993231 11 minutes ago
Remember though that there are 10 million extra shares on loan that are not reported as shorted.  Those shares could be in the hands of shorts to play, or perhaps they are borrowed by an organization or individual that wants to force something else. 

If most are in the hands of the s
LWLG
makinezmoney makinezmoney 12 minutes ago
$NA: Just amazing........... now $22

3 weeks still running higher from a start of $3.50


WOW wwaaaaa weee wwwwwahhhhhhhhhhhhhh


GO $NA
NA
boi568 boi568 13 minutes ago
120 of those review days have already passed -- and that review clock is stopped right now while Anavex is preparing a response to reviewer questions. So the variable is Anavex, and then there are up to 90 days of additional EMA review and a potential second clock stop before the EMA issues a go or
AVXL
DMC8 DMC8 13 minutes ago
https://www.stocktitan.net/news/AMRN/amarin-announces-exclusive-license-and-supply-agreement-with-0ym8l9gnpaef.html
AMRN
threewheeler threewheeler 13 minutes ago
AZRH looking forward to getting more info from Controled as 3 more posts no one sees, will be entertain as are all the responses blowing up fake posts with real facts
AZRH
Nelson2 Nelson2 14 minutes ago
Well, boyz time for the verdict
A stroke of luck with ceasefire announcement. Up premarket
Now let’s run like a raped ape at the open!

GLTA
BB
subslover subslover 16 minutes ago
SunHydrogen to Deploy more than 30 m² Hydrogen Production Pilot System in Collaboration with UT Austin
First large-scale multi-panel solar-to-hydrogen system to be installed at UT Austin’s Hydrogen ProtoHub, featuring sixteen photoelectrochemical hydrogen reactors totaling more than 30m² in a
HYSR
Monksdream Monksdream 17 minutes ago
Nano Labs Announces US$500 Million Convertible Notes Private Placement for BNB Treasury Strategy
June 24 2025 - 6:00AM

Alert
Print
Share On Facebook

Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading Web 3.0 infrastructure
nyt nyt 18 minutes ago
Nothing more than just another of the many many monkey wrenches I've predicted and have manifested for yrs and yrs that never, I repeat, NEVER, amount to anything of substance. Reason being there is no substance. Vplm, in all its glory is nothing more than dryer fluff, pocket lint, the daily trash.
VPLM
makinezmoney makinezmoney 19 minutes ago
$INM: Awaaayyyyyyy she goes.... now $4.50

Big premarket booster from just 2.50

NICEEeeeeeeeeeeeeeeeeeeeee


GO $INM
INM
Monksdream Monksdream 20 minutes ago
INM
INM
GoodGuyBill GoodGuyBill 20 minutes ago
Most people who disagree with a particular claim do so by presenting counter arguments not baseless personal attacks. This response to a reasonable post lakes any credibility whatsoever. I don't understand how posts like this-- referring to people as liars, are allowed. TOS violation?
NWBO
pepeoil pepeoil 20 minutes ago
Oh yea Joshy, I don’t see you on the Texas RRC approved pluggers list. You can’t do it yourself. Bwahaaaaaa. You have to hire someone to come crush your cement. Bwahaaaaa.
AZRH
Scotty9 Scotty9 21 minutes ago
O my prophet what else do you see in the tickers please tell us all
TWOH
Monksdream Monksdream 22 minutes ago
iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results
June 24 2025 - 7:00AM

Alert
Print
Share On Facebook

iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of next-generation antibody
IBIO
Investor2014 Investor2014 24 minutes ago
We have no idea and just invest because it all sounds cool or believe TA will tell us, so you seem to have joined the right party.
AVXL

Your Recent History

USOTC
ARTH
Arch Therapeutics (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads